Could a temperature-resistant vaccine spell the end for rabies and yellow fever?

Current vaccines for rabies and yellow fever are plagued by the difficulties of transporting temperature-controlled drugs. A new European consortium led by KU Leuven may have the solution. Elly Earls reports.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news